Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on December 17, 2007

Circulation. 2007
Published online before print December 17, 2007, doi: 10.1161/CIRCULATIONAHA.107.709204
A more recent version of this article appeared on January 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
117/1/93    most recent
CIRCULATIONAHA.107.709204v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ageno, W.
Right arrow Articles by Kamphuisen, P. W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ageno, W.
Right arrow Articles by Kamphuisen, P. W.
Related Collections
Right arrow Deep vein thrombosis
Right arrow Risk Factors
Right arrowRelated Article

Submitted on April 13, 2007
Accepted on October 12, 2007

Cardiovascular Risk Factors and Venous Thromboembolism. A Meta-Analysis

Walter Ageno MD*, Cecilia Becattini MD, Timothy Brighton MD, Rita Selby MD, and Pieter W. Kamphuisen MD

From the Department of Clinical Medicine, University of Insubria, Varese, Italy (W.A.); Department of Internal Medicine, University of Perugia, Italy (C.B.); SEALS, Prince of Wales Hospital, Sydney, Australia (T.B.); Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada (R.S.); and Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands (P.W.K.).

* To whom correspondence should be addressed. E-mail: agewal{at}yahoo.com.

Background—The concept that venous thromboembolism (VTE) and atherosclerosis are 2 completely distinct entities has recently been challenged because patients with VTE have more asymptomatic atherosclerosis and more cardiovascular events than control subjects. We performed a meta-analysis to assess the association between cardiovascular risk factors and VTE.

Methods and Results—Medline and EMBASE databases were searched to identify studies that evaluated the prevalence of major cardiovascular risk factors in VTE patients and control subjects. Studies were selected using a priori defined criteria, and each study was reviewed by 2 authors who abstracted data on study characteristics, study quality, and outcomes. Odds ratios or weighted means and 95% confidence intervals (CIs) were then calculated and pooled using a random-effects model. Statistical heterogeneity was evaluated through the use of {chi}2 and I2 statistics. Twenty-one case-control and cohort studies with a total of 63 552 patients met the inclusion criteria. Compared with control subjects, the risk of VTE was 2.33 for obesity (95% CI, 1.68 to 3.24), 1.51 for hypertension (95% CI, 1.23 to 1.85), 1.42 for diabetes mellitus (95% CI, 1.12 to 1.77), 1.18 for smoking (95% CI, 0.95 to 1.46), and 1.16 for hypercholesterolemia (95% CI, 0.67 to 2.02). Weighted mean high-density lipoprotein cholesterol levels were significantly lower in VTE patients, whereas no difference was observed for total and low-density lipoprotein cholesterol levels. Significant heterogeneity among studies was present in all subgroups except for the diabetes mellitus subgroup. Higher-quality studies were more homogeneous, and significant associations remained unchanged.

Conclusions—Cardiovascular risk factors are associated with VTE. This association is clinically relevant with respect to individual screening, risk factor modification, and primary and secondary prevention of VTE. Prospective studies should further investigate the underlying mechanisms of this relationship.


Key words: atherosclerosis • risk factors • thrombosis • veins


Related Article:

Clinical Summaries
Circulation 2008 117: 1-3. [Full Text]